David R. Gandara, MD, was honored as the lung cancer “Giant of Cancer Care” in the 2017 Giants of Cancer Care® recognition program by OncLive. Awardees are selected by their […] Read more
Editor’s Note: IASLC Lung Cancer News is pleased to publish this article as part of its continuing focus on the expansion of “combustible tobacco” (cigarettes) to include non-combustible products and […] Read more
Roman V. Petrov, MD, PhD, has been appointed Assistant Professor, Department of Surgical Oncology, Fox Chase Cancer Center; and Assistant Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine, […] Read more
Gideon M. Blumenthal, MD was named Acting Deputy Director, Office of Hematology & Oncology Products, US Food and Drug Administration, Silver Spring, US. Prior to this appointment, Dr. Blumenthal was […] Read more
Based on global ALEX, has crizotinib been relegated to the therapeutic scrapheap when it comes to patients with ALK rearrangements? Or does it retain some role? The global ALEX study, […] Read more
Please give us a global perspective on the results of global ALEX. Will alectinib definitively displace crizotinib or ceritinib as the first-line treatment for ALK-rearranged non-small cell lung cancer (NSCLC)? […] Read more
By Fabrice Barlesi, MD, PhD, and Eric Vallières, MD, FRCSC An article by Cynthia Kryder and Ramón Rami-Porta in the IASLC Lung Cancer News recently highlighted the innovations of the […] Read more
By Luis E. Raez, MD The IASLC-Latin American Group (LATAM) successfully organized another “Workshop in Lung Cancer Clinical Research,” as it has done before in other countries like Chile and […] Read more
Clinical Trial Leader and Patient Champion Passes Away at 71 Robert L. Comis, MD, passed away suddenly in his home on May 10, 2017. He was 71. A leader in […] Read more
By Gian Piero Bandelli, MD, Federica Ferraresi, WALCE Advocate, and Silvia Novello, MD, PhD On the occasion of World No Tobacco Day 2017, Women Against Lung Cancer in Europe (WALCE), […] Read more